foxo4-dri senolytic 2023 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Senolytic Peptide FOXO4-DRI Selectively Removes

I feel so successful that I can get in and out of the car and walk normally

Compound GHK-Cu (Copper Tripeptide-1) CAS Number 89030-95-5 Sequence Gly-His-Lys (copper-bound) Molecular weight ~403.9 g/mol Purity 99% (HPLC verified) Form Lyophilised powder Contents 50mg or 100mg per vial Packaging Sealed sterile research vial Storage (lyophilised) 28C, protect from light & moisture Storage (reconstituted) 28C, use within 28 days Reconstitution Bacteriostatic water (recommended)

Hair Loss: Diagnosis and Treatment

Start with our peptide therapy overview, then book a consult to build a protocol that matches your body, your training, and your timeline